Want to join the conversation?
$ASNA said that for FY16, the company is cutting its revenue outlook to approx. $7.1Bil and adjusted EPS outlook to $0.67-0.70 from $0.75-0.80. During 3Q16, $ASNA made a $5MM required amortization payment on its $1.8Bil term loan. The company did not repurchase any additional shares under its existing $200MM buyback authorization.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)